BiotechTube
PanThera Bio

PanThera Bio

London, United Kingdom· Est.
pantheraclinic.co.uk
Is this your company? Claim your profile to update info and connect with investors.
Claim profile

Private Company

Total funding raised: $2.5M

Overview

PanThera Bio is a private, London-based clinical research services company that accelerates clinical trials for pharmaceutical sponsors, primarily in oncology and immunology. It differentiates itself through a patient-centric recruitment model and claims to significantly reduce site activation and patient enrollment timelines compared to public sector benchmarks. The company is revenue-generating, operating as a service provider for clinical trial sponsors, and leverages its operational efficiency as a key value proposition.

OncologyImmunology

Technology Platform

Operational platform for accelerated clinical trial site start-up and patient recruitment, claiming to reduce activation timelines by over 3 months compared to public sector benchmarks.

Funding History

1
Total raised:$2.5M
Seed$2.5M

Opportunities

The growing global clinical trials market and persistent sponsor need for faster, cheaper patient recruitment present a major opportunity.
The UK government's push to become a clinical research leader and the inefficiency of public sector site activation provide a clear niche for PanThera's claimed faster start-up model.

Risk Factors

Key risks include intense competition from large global CROs, dependency on winning sponsor contracts, and the performance risk of failing to deliver on its promised accelerated timelines.
Regulatory compliance failures could severely damage its reputation and business.

Competitive Landscape

PanThera competes in the fragmented clinical research organization (CRO) and patient recruitment sector. It faces competition from large, full-service global CROs (e.g., IQVIA, ICON) and smaller niche recruitment firms. Its differentiation is its claimed operational speed in the UK market versus the NHS.

More companies in United Kingdom →